
One Blue plan says where it spends premiums
There is a lot of attention now on the financial stability of health insurers in the individual market following Aetna’s announcement about pulling back from individual coverage in eleven states. Skeptics sometimes doubt whether financial losses cited in such news are truly the case. And the relative lack of transparency in health care often doesn’t help resolve such questions easily.
That’s part of why a “tweetstorm” today from Blue Cross Blue Shield of Louisiana economist Michael Bertaut was helpful. Mike took a break from flood-related topics to share these thoughts on how his Blue spends the premium dollar (aside: if you want to learn more about how life-altering the flooding in Baton Rouge has been, read Mike’s post on the topic at his employer’s blog).
Here’s the tweetstorm:
Ready for my morning TweetStorm? Here's what I call total Transparency on a health plan, BCBS Louisiana where I work.
— Michael Bertaut (@MikeBertaut) August 25, 2016
First the financials. This is public domain if anybody cares to verify, but I've presented on this data almost 100 times just in 2016,
— Michael Bertaut (@MikeBertaut) August 25, 2016
What did our small health plan do with the premiums we took in. We are at risk for roughly 650,000 people's healthcare.
— Michael Bertaut (@MikeBertaut) August 25, 2016
Last year (2015), we took in $3.14Billion in premiums from them. And here is exactly how we spent it.
— Michael Bertaut (@MikeBertaut) August 25, 2016
41% of premiums right off the top went directly to pay an inpatient hospital bill for our members. That's $1.29B straight to hospitals.
— Michael Bertaut (@MikeBertaut) August 25, 2016
27% of premiums, $848m paid Doctor bills and for outpatient services ordered by Docs outside of hospital.
— Michael Bertaut (@MikeBertaut) August 25, 2016
19% of premiums, $597m went for drugs administered outside of inpatient stays. Those are bundled. So total medical spend = 87% of premiums
— Michael Bertaut (@MikeBertaut) August 25, 2016
Another 3%, almost $100m paid taxes and fees, including the new Carrier fees imposed by PPACA. Outside sales fees another $100m, 3%.
— Michael Bertaut (@MikeBertaut) August 25, 2016
And internal expenses (payroll, insurance, IT, marketing, etc) totaled 7% of all premiums in 2015. That's 102% total (ran loss).
— Michael Bertaut (@MikeBertaut) August 25, 2016
So, the answer to the question (What is BCBSLA doing with all my money!) is as follows:
— Michael Bertaut (@MikeBertaut) August 25, 2016
41% inpatient hospital, 27% Doctor/outpatient, 19% pharma, 3% taxes/fees, 7% internal business operations, 4% external in 2015,
— Michael Bertaut (@MikeBertaut) August 25, 2016
This activity resulted in an $80m loss on Individual Products, which drove a $65m loss across the board.
— Michael Bertaut (@MikeBertaut) August 25, 2016
So now the question is, IF you want to reduce health insurance premiums, where do you start? Where is biggest bang for buck? Discuss!
— Michael Bertaut (@MikeBertaut) August 25, 2016
I might add, that pharma was 12% of premiums in 2005, may very well hit 25% of premiums in 2016. What is THAT crowding out?
— Michael Bertaut (@MikeBertaut) August 25, 2016
That was a lot of data packed into 140 character chunks, but here are a few key takeaways:
- Many local Blue plans, like Louisiana are non-profits. They’re not charities and they’re not trying to maximize profits like publicly traded companies, but they’re not in business to lose money. Losing $65 million overall in 2015 based on an $80 million loss in the individual market is not sustainable. And those results are not uncommon for local insurers across the country.
- 87 cents on the premium dollar is a lot of money on medical care. If administrative costs are only seven cents on the dollar, it becomes pretty clear what area of spending requires the most attention.
- Tucked into that last tweet is the issue of prescription drug costs, a skyrocketing problem for every health insurer (and employers who self-fund their own benefits). Mike’s point is a provocative one: what else has to give in order to cover those soaring drug costs?
Interesting how more data can yield more questions, but transparency like this is a good addition to the discourse.